Global Implantable Drug Delivery Devices Market by Products, Technologies, Applications and Forecast to 2020, New Findings by iHealthcareAnalyst, Inc.
Implantable Drug Delivery Devices Market by Device Types (Bio-Absorbable Stents, Brachytherapy Seeds, Contraceptive Devices, Coronary Drug Eluting Stents, Drug Infusion Pumps, and Intraocular Devices), Technologies (Biodegradable and Non-Biodegradable), and Applications (Contraception, Cardiovascular, Oncology, Ophthalmology, Diabetes, Chronic Pain) 2016-2020
Maryland Heights, MO, March 11, 2017 --(PR.com)-- The global implantable drug delivery devices market is estimated to reach USD 22.5 Billion in 2020, growing at a CAGR of 6.0% from 2016 to 2020, due to higher demand for minimally invasive technologies worldwide.
Browse Implantable Drug Delivery Devices Market by Device Types (Bio-Absorbable Stents, Brachytherapy Seeds, Contraceptive Devices, Coronary Drug Eluting Stents, Drug Infusion Pumps, and Intraocular Devices), Technologies (Biodegradable and Non-Biodegradable), and Applications (Contraception, Cardiovascular, Oncology, Ophthalmology, Diabetes, Chronic Pain) 2016-2020 report at https://www.ihealthcareanalyst.com/report/implantable-drug-delivery-devices-market/
Implantable drug delivery devices serve a variety of functions, from vascular stents that preserve blood flow to electro stimulation devices that regulate heart rhythm or block spurious signals in the brain to orthopedic devices that mechanically reinforce the spine or restore range of motion of hips and knees. Implantable devices allow site specific drug administration and allow for sustained release of a therapeutic agents, while the key material considerations include biocompatibility, stability and durability. Higher prevalence of prostate cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, colorectal cancer, unwanted pregnancies and rapidly aging global population are the driving the global implantable drug delivery devices market.
The global implantable drug delivery devices market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on device type (bio-absorbable stents, brachytherapy seeds, contraceptive devices, coronary drug eluting stents, drug infusion pumps, and intraocular devices), their underlying technologies (biodegradable and non-biodegradable), its applications (contraception, cardiovascular, oncology, ophthalmology, diabetes, chronic pain, etc.), and also forecasts growth trends (CAGR% - 2016 to 2020). The global implantable drug delivery devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global implantable drug delivery devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global implantable drug delivery devices market and included in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/implantable-drug-delivery-devices-market/
About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Browse Implantable Drug Delivery Devices Market by Device Types (Bio-Absorbable Stents, Brachytherapy Seeds, Contraceptive Devices, Coronary Drug Eluting Stents, Drug Infusion Pumps, and Intraocular Devices), Technologies (Biodegradable and Non-Biodegradable), and Applications (Contraception, Cardiovascular, Oncology, Ophthalmology, Diabetes, Chronic Pain) 2016-2020 report at https://www.ihealthcareanalyst.com/report/implantable-drug-delivery-devices-market/
Implantable drug delivery devices serve a variety of functions, from vascular stents that preserve blood flow to electro stimulation devices that regulate heart rhythm or block spurious signals in the brain to orthopedic devices that mechanically reinforce the spine or restore range of motion of hips and knees. Implantable devices allow site specific drug administration and allow for sustained release of a therapeutic agents, while the key material considerations include biocompatibility, stability and durability. Higher prevalence of prostate cancer, diabetic retinopathy, chronic pain causing diseases, cardiovascular diseases, colorectal cancer, unwanted pregnancies and rapidly aging global population are the driving the global implantable drug delivery devices market.
The global implantable drug delivery devices market report provides market size estimates (Revenue USD million - 2013 to 2020) for key market segments based on device type (bio-absorbable stents, brachytherapy seeds, contraceptive devices, coronary drug eluting stents, drug infusion pumps, and intraocular devices), their underlying technologies (biodegradable and non-biodegradable), its applications (contraception, cardiovascular, oncology, ophthalmology, diabetes, chronic pain, etc.), and also forecasts growth trends (CAGR% - 2016 to 2020). The global implantable drug delivery devices market research report is further segmented by geography into North America (U.S., Canada), Latin America (Brazil, Mexico, Rest of LA), Europe (U.K., Germany, France, Italy, Spain, Rest of EU), Asia Pacific (Japan, China, India, Rest of APAC), and Rest of the World. The global implantable drug delivery devices market report also provides the detailed market landscape (market drivers, restraints, opportunities), market attractiveness analysis and also tracks the major competitors operating in the market and provides analysis of the company overview, financial snapshot, key products, technologies and services offered, market share analysis and recent trends in the global market.
Major players operating in the global implantable drug delivery devices market and included in this report are Allergan Inc, Bayer HealthCare, Medtronic Inc., Nucletron, Merck, pSivida Corp., Boston Scientific Corporation, Abbott Laboratories and Bausch and Lomb Inc.
To request Table of Contents and Sample Pages of this report visit: https://www.ihealthcareanalyst.com/report/implantable-drug-delivery-devices-market/
About Us
iHealthcareAnalyst, Inc. is a global healthcare market research and consulting company providing market analysis, and competitive intelligence services to global clients. The company publishes syndicate, custom and consulting grade healthcare reports covering animal healthcare, biotechnology, clinical diagnostics, healthcare informatics, healthcare services, medical devices, medical equipment, and pharmaceuticals.
In addition to multi-client studies, we offer creative consulting services and conduct proprietary single-client assignments targeted at client’s specific business objectives, information needs, time frame and budget. Please contact us to receive a proposal for a proprietary single-client study.
Contact Us
iHealthcareAnalyst, Inc.
2109, Mckelvey Hill Drive,
Maryland Heights, MO 63043
United States
Email: sales@ihealthcareanalyst.com
Website: https://www.ihealthcareanalyst.com
Contact
iHealthcareAnalyst, Inc.
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
Ana Aitawa
(314) 500-7508
https://www.ihealthcareanalyst.com/
Contact
Categories